Subfoveal Nodule Affecting Visual Prognosis in Coats Disease
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: To investigate the characteristics of subfoveal nodules in Korean patients with Coats disease and their association with visual outcomes Methods: A retrospective analysis was conducted within the medical records of patients with stage 2B or 3A1 Coats disease, including clinical features, imaging, presence of either a subfoveal nodule or macular fibrosis, and visual outcome. Results: Twelve patients were present with stage 2B or 3A1 Coats disease, and nine patients (75%) presented with subfoveal nodule. Between the group without subfoveal nodule and the group with subfoveal nodule, there were no significant differences in age (mean, 14.0 ± 1.7 years vs. 27.7 ± 21.8 years; p = 0.482), sex (all men), stage of the disease (stage 2B: three patients vs. eight patients, p > 0.999; stage 3A1: none vs. one patient, p > 0.999), extension of retinal exudation (mean, 7.7 hours vs. 4.1 hours; p = 0.209) and peripheral telangiectasia (mean, 3.7 hours vs. 4.2 hours; p = 0.727), and follow-up duration (mean, 65.0 months vs. 46.1 months; p = 0.600). There were significantly more patients with severe visual loss (≤20 / 200) among the patients with subfoveal nodule (none vs. seven patients, p = 0.045), and the cause for severe visual loss was macular fibrosis in all cases. Macular fibrosis developed significantly more frequently in the patients with subfoveal nodule (none vs. seven = patients, p = 0.045). Conclusions: This study is the first study covering the analysis of subfoveal nodules in Korean patients with Coats disease. The existence of a subfoveal nodule at the initial diagnosis serves as an indicator predicting the development of macular fibrosis and a less favorable visual outcome in the patients with Coats disease. A multicenter study with a larger patient pool and further studies toward the therapeutic approach for the subfoveal nodule and macular fibrosis are needed.
Abstract
Purpose: To investigate the characteristics of subfoveal nodules in Korean patients with Coats disease and their association with visual outcomes Methods: A retrospective analysis was conducted within the medical records of patients with stage 2B or 3A1 Coats disease, including clinical features, imaging, presence of either a subfoveal nodule or macular fibrosis, and visual outcome. Results: Twelve patients were present with stage 2B or 3A1 Coats disease, and nine patients (75%) presented with subfoveal nodule. Between the group without subfoveal nodule and the group with subfoveal nodule, there were no significant differences in age (mean, 14.0 ± 1.7 years vs. 27.7 ± 21.8 years; p = 0.482), sex (all men), stage of the disease (stage 2B: three patients vs. eight patients, p > 0.999; stage 3A1: none vs. one patient, p > 0.999), extension of retinal exudation (mean, 7.7 hours vs. 4.1 hours; p = 0.209) and peripheral telangiectasia (mean, 3.7 hours vs. 4.2 hours; p = 0.727), and follow-up duration (mean, 65.0 months vs. 46.1 months; p = 0.600). There were significantly more patients with severe visual loss (≤20 / 200) among the patients with subfoveal nodule (none vs. seven patients, p = 0.045), and the cause for severe visual loss was macular fibrosis in all cases. Macular fibrosis developed significantly more frequently in the patients with subfoveal nodule (none vs. seven = patients, p = 0.045). Conclusions: This study is the first study covering the analysis of subfoveal nodules in Korean patients with Coats disease. The existence of a subfoveal nodule at the initial diagnosis serves as an indicator predicting the development of macular fibrosis and a less favorable visual outcome in the patients with Coats disease. A multicenter study with a larger patient pool and further studies toward the therapeutic approach for the subfoveal nodule and macular fibrosis are needed.
참고문헌 (10)
- Coats G, "Forms of retinal diseases with massive exudation", R Lond Ophthalmol Hosp Rep, 17, pp.440~525 (1908)
- Shields JA, "Classification and management of Coats disease : the 2000 Proctor Lecture", Am J Ophthalmol, 131, pp.572~583 (2001)
- Khurana RN, "Subfoveal nodule in Coats’ disease", Clin Exp Ophthalmol, 33, pp.301~302 (2005)
- Jumper JM, "Macular fibrosis in Coats disease", Retina, 30(4 Suppl), pp.S9~S14 (2010)
- Daruich AL, "Subfoveal nodule in Coats’ disease : toward an updated classification predicting visual prognosis", Retina, 37, pp.1591~1598 (2017)
- Chang MM, "Coats’ disease : a study of 62 histologically confirmed cases", J Pediatr Ophthalmol Strabismus, 21, pp.163~168 (1984)
- Daruich A, "Extramacular fibrosis in Coats’ disease", Retina, 36, pp.2022~2028 (2016)
- Cahill M, "Classification of the spectrum of Coats’ disease as subtypes of idiopathic retinal telangiectasis with exudation", Acta Ophthalmol Scand, 79, pp.596~602 (2001)
- Matet A, "Macular telangiectasia type 1 : capillary density and microvascular abnormalities assessed by optical coherence tomography angiography", Am J Ophthalmol, 167, pp.18~30 (2016)
- Sigler EJ, "Retinal angiomatous proliferation with chorioretinal anastomosis in childhood Coats disease : a reappraisal of macular fibrosis using multimodal imaging", Retina, 35, pp.537~546 (2015)